Cutler Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Cutler Group’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-100	Closed	-$3K	–	6766
2021 Q2	$3K	Buy	+100	New	+$2.55K	﹤0.01%	4912
2021 Q1	–	Sell	-100	Closed	-$2K	–	6609
2020 Q4	$2K	Buy	+100	New	+$2.52K	﹤0.01%	4322
2020 Q3	–	Sell	-3,100	Closed	-$93K	–	5482
2020 Q2	$93K	Buy	+3,100	New	+$112K	0.01%	1353
2020 Q1	–	Sell	-4,900	Closed	-$170K	–	4939
2019 Q4	$230K	Buy	+4,900	New	+$141K	0.01%	760

Cutler Group's CNST Position: Q3 2021 in Review

Cutler Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 100 shares — an estimated $3K sold.

Cutler Group first reported a position in CNST in Q4 2019 and held it in 4 quarters. The position peaked at $230K in Q4 2019. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Cutler Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Cutler Group sold 100 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $3K.
Cutler Group first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 4 quarters.
Cutler Group's Constellation Pharmaceuticals, Inc. position peaked at $230K in Q4 2019.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Cutler Group's 13F filing for Q3 2021, filed 26 Oct 2021.